Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
14.6%
% of GNOM's 41 holdings also in PBE
21.4%
% of PBE's 28 holdings also in GNOM
Overlap by Weight
Sector Drift (GNOM minus PBE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in GNOM |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
BIOMARIN PHARMACEUTICAL INC | 3.7% | 5.3% | 3.7% |
|
BIO-TECHNE CORPORATION | 3.5% | 4.7% | 3.5% |
|
MYRIAD GENETICS INC | 2.8% | 2.3% | 2.3% |
|
VERACYTE INC | 2.7% | 2.3% | 2.3% |
|
VERTEX PHARMACEUTICALS INC | 1.9% | 5.0% | 1.9% |
Position Highlights (Non-Overlapping Exposures)
GNOM Overweight Relative to PBE
 |
ENI SPA-SPONSORED ADR | 7.7% |
|
NATERA INC | 7.3% |
|
CRISPR THERAPEUTICS AG | 4.8% |
|
MODERNA, INC. | 4.5% |
|
ULTRAGENYX PHARMACEUTICAL IN | 4.4% |
|
AGILENT TECHNOLOGIES INC | 4.4% |
|
SAREPTA THERAPEUTICS INC | 3.7% |
|
QIAGEN NV | 3.6% |
|
ILLUMINA INC | 3.5% |
|
ROCKET PHARMACEUTICALS, INC. | 3.3% |
GNOM Underweight Relative to PBE
|
NEUROCRINE BIOSCIENCES INC | -5.3% |
|
AMGEN INC | -5.1% |
|
REGENERON PHARMACEUTICALS | -5.1% |
|
BIOGEN IDEC INC | -4.7% |
|
GILEAD SCIENCES INC | -3.5% |
|
UNITED THERAPEUTICS CORP | -3.2% |
|
CATALYST PHARMACEUTICAL PART | -3.2% |
|
EXELIXIS INC | -3.2% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -3.2% |
|
VERTEX PHARMACEUTICALS INC | -3.1% |